Want to join the conversation?
$ZBH expects gross margin to be in a range of 75.0-75.7% in 2H16, consistent with 1H16. The company now estimates R&D expense to be in a range of 4.7-5.2% of sales in 2H16, and SG&A expense to be in a range of 37.5-39.5%. $ZBH expects the effective tax rate in 2H16 to be approx. 25%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?